Oppenheimer Maintains an 'Outperform' on Brinks Co. (BCO); Meeting with Management
Tweet
Share
E-mailGet Alerts BCO Hot Sheet
Price: $109.14 -1.92%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Oppenheimer maintains an 'Outperform' on Brinks Co. (NYSE: BCO) price target of $30.00.
Analyst, Ian Zaffino, said, "Europe remains a surprising bright spot, driven by strong Global Services volumes. The US should meet its segment margin goal of 4.5-5.5% in 2012. BCO continues to rein-in capex and will fund its pension with cash, rather than stock. Management has compensation incentives to raise margins to 10% by 2015 (e.g., adjusted EPS of ~$4), vs. 6.8% in 2012E."
For an analyst ratings summary and ratings history on Brinks Co. click here. For more ratings news on Brinks Co. click here.
Shares of Brinks Co. closed at $23.31 yesterday.
Analyst, Ian Zaffino, said, "Europe remains a surprising bright spot, driven by strong Global Services volumes. The US should meet its segment margin goal of 4.5-5.5% in 2012. BCO continues to rein-in capex and will fund its pension with cash, rather than stock. Management has compensation incentives to raise margins to 10% by 2015 (e.g., adjusted EPS of ~$4), vs. 6.8% in 2012E."
For an analyst ratings summary and ratings history on Brinks Co. click here. For more ratings news on Brinks Co. click here.
Shares of Brinks Co. closed at $23.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Raymond James Resumes Safehold (SAFE) at Market Perform
- Outlook Therapeutics Inc. (OTLK) PT Lowered to $4 at Brookline Capital Markets
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
